These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20410217)

  • 21. Superoxide formation and interaction with nitric oxide modulate systemic arterial pressure and renal function in salt-depleted dogs.
    Dutta UK; Lane J; Roberts LJ; Majid DS
    Exp Biol Med (Maywood); 2006 Mar; 231(3):269-76. PubMed ID: 16514172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and renal effects of acute and progressive nitric oxide synthesis inhibition in anesthetized dogs.
    Cases A; Haas J; Burnett JC; Romero JC
    Am J Physiol Regul Integr Comp Physiol; 2001 Jan; 280(1):R143-8. PubMed ID: 11124145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
    Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of big endothelin-1-induced diuresis and natriuresis : role of ET(B) receptors.
    Hoffman A; Abassi ZA; Brodsky S; Ramadan R; Winaver J
    Hypertension; 2000 Mar; 35(3):732-9. PubMed ID: 10720587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide and renal effects of volume expansion in conscious monkeys.
    Peterson TV; Carter AB; Miller RA
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1033-8. PubMed ID: 9139998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of blood pressure salt-sensitivity supports a preglomerular site of action of nitric oxide in Type I diabetic rats.
    Brands MW; Bell TD; Fleming C; Labazi H; Sturgis LC
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):475-9. PubMed ID: 17439418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
    Clayton JS; Clark KL; Johns EJ; Drew GM
    Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects.
    van der Linde NA; van den Meiracker AH; Boomsma F
    J Hypertens; 2003 Feb; 21(2):345-51. PubMed ID: 12569265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism underlying diuretic effect of L-NAME at a subpressor dose.
    Liang M; Berndt TJ; Knox FG
    Am J Physiol Renal Physiol; 2001 Sep; 281(3):F414-9. PubMed ID: 11502590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-A blockade attenuates systemic and renal hemodynamic effects of L-NAME in humans.
    Montanari A; Biggi A; Carra N; Fasoli E; Calzolari M; Corsini F; Perinotto P; Novarini A
    Hypertension; 2000 Jan; 35(1 Pt 2):518-23. PubMed ID: 10642352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs.
    Majid DS; Nishiyama A
    Hypertension; 2002 Feb; 39(2):293-7. PubMed ID: 11847200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide may prevent hypertension early in diabetes by counteracting renal actions of superoxide.
    Brands MW; Bell TD; Gibson B
    Hypertension; 2004 Jan; 43(1):57-63. PubMed ID: 14656952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pressure natriuresis following acute and chronic inhibition of nitric oxide synthase in rats.
    Guarasci GR; Kline RL
    Am J Physiol; 1996 Feb; 270(2 Pt 2):R469-78. PubMed ID: 8779881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemically administered tempol reduces neuronal activity in paraventricular nucleus of hypothalamus and rostral ventrolateral medulla in rats.
    Wei SG; Zhang ZH; Yu Y; Felder RB
    J Hypertens; 2009 Mar; 27(3):543-50. PubMed ID: 19330914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide modulates the development and surgical reversal of renovascular hypertension in rats.
    Huang WC; Tsai RY; Fang TC
    J Hypertens; 2000 May; 18(5):601-13. PubMed ID: 10826564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.
    Broere A; Van Den Meiracker AH; Boomsma F; Derkx FH; Veld AJ; Schalekamp MA
    Am J Physiol; 1998 Dec; 275(6):F870-7. PubMed ID: 9843903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal nitric oxide synthase, nNOS, regulates renal hemodynamics in the postnatal developing piglet.
    Rodebaugh J; Sekulic M; Davies W; Montgomery S; Khraibi A; Solhaug MJ; Ratliff BB
    Pediatr Res; 2012 Feb; 71(2):144-9. PubMed ID: 22258124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute intracerebroventricular insulin microinjection after nitric oxide synthase inhibition of renal sodium handling in rats.
    Furlan FC; Marshall PS; Macedo RF; Carvalheira JB; Michelotto JB; Gontijo JA
    Life Sci; 2003 Apr; 72(23):2561-9. PubMed ID: 12672502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.